Q2 FY2026 · ended Jun 30, 2026 · Revenue $3.90M, +44.8% YoY · Filed Aug 6, 2026
Hyperfine, Inc. (HYPR) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $3.9 million and a net loss of $9.3 million. Free cash flow was -$7.3 million. As of Jun 30, 2026 it held $43.5 million in cash and investments and $13.4 million in total debt.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- HYPR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Guilford, CT
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1833769
- Former names
- HealthCor Catalio Acquisition Corp. (until Dec 22, 2021)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $3.9M | $3.9M | $5.3M | $3.4M | $2.7M |
| Operating income | -$8.5M | -$8.6M | -$7.7M | -$8.9M | -$9.6M |
| Net income | -$9.3M | -$8.6M | -$5.9M | -$11.0M | -$9.2M |
| Diluted EPS | -$0.09 | -$0.09 | -$0.06 | -$0.14 | -$0.12 |
| Operating cash flow | -$7.3M | -$9.0M | -$5.2M | -$5.6M | -$7.9M |
| Free cash flow | -$7.3M | -$9.2M | -$5.3M | -$5.7M | -$8.4M |
| Total assets | $63.0M | $60.3M | $55.3M | $41.5M | $45.2M |
| Total liabilities | $26.2M | $26.0M | $14.3M | $14.6M | $10.1M |
| Stockholders' equity | $36.8M | $34.4M | $41.0M | $26.9M | $35.1M |
| Cash and investments | $43.5M | $40.8M | $35.1M | $21.6M | $25.4M |
| Total debt | $13.4M | $13.4M | $314,000 | $182,000 | $250,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 8, 2026 | Oct 8, 2026 |
| 8-K |
Current report
Listing notice
|
Sep 18, 2026 | Sep 17, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 21, 2026 | May 21, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
All 367 Hyperfine, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.